Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice.
OBJECTIVE
Eradication of Helicobacter pylori infections in humans results in the healing of gastritis and gastric ulcers. This study used a mouse model to test whether oral vaccination can cure Helicobacter infection and gastritis.


METHODS
Mice were infected with Helicobacter felis. Three weeks after infection, the mice were orally immunized with H. pylori urease B subunit. Control mice were simultaneously infected but sham immunized.


RESULTS
Three to 8 weeks after oral immunization of H. felis-infected mice with recombinant H. pylori urease B subunit, the infection cleared and there was no evidence of gastritis. Vaccinated mice remained protected against two consecutive H. felis challenges.


CONCLUSIONS
These results show that the lack of natural immunity against Helicobacter can be overcome by oral immunization and that vaccination offers a novel therapeutic approach to Helicobacter-induced gastritis.
Corthésy-Theulaz
I
I
Division of Gastroenterology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Porta
N
N
Glauser
M
M
Saraga
E
E
Vaney
A C
AC
Haas
R
R
Kraehenbuhl
J P
JP
Blum
A L
AL
Michetti
P
P
D000284:Administration, Oral; D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D016481:Helicobacter Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D016480:Helicobacter pylori / Q000201:enzymology*; D007167:Immunotherapy; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D014510:Urease / Q000008:administration & dosage / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014510:Urease